TY - JOUR
T1 - Lymphatic Micrometastases in Patients With Early Esophageal Adenocarcinoma
AU - Grotenhuis, Brechtje A.
AU - van Heijl, Mark
AU - Wijnhoven, Bas P. L.
AU - Henegouwen, Mark I. van Berge
AU - Biermann, Katharina
AU - ten Kate, Fiebo J. W.
AU - Busch, Olivier R. C.
AU - Dinjens, Winand N. M.
AU - Tilanus, Hugo W.
AU - van Lanschot, J. Jan B.
PY - 2010
Y1 - 2010
N2 - Background: Both endoscopic and surgical treatments are recommended for m3- or sm1-adenocarcinomas of the esophagus, depending on patients' lymph nodal status. Lymphatic dissemination is related to tumor infiltration depth, but varying incidences have been reported in m3- and sm1-adenocarcinomas. The study aim was to investigate whether the presence of occult tumor cells in lymph nodes could explain this variation. Methods: Sixty-three node-negative (NO) patients with early esophageal adenocarcinoma (m2/m3/sm1-tumors) were included. Multilevel-sectioning of lymph nodes was performed; sections were stained by means of immunohistochemistry with cytokeratin marker CAM5.2. Two pathologists searched for micrometastases (0.2-2.0 mm) and isolated tumor cells (ITCs, <0.2 mm). Results: Positive CAM5.2 staining in lymph nodes was not seen in any of the 18 m2-patients. In 2/25m3-tumors (8.0%) an ITC was found, but no micrometastases. Tumor cells were identified in 4/20 sm1-tumors (20.0%): three micrometastases and one ITC. Median follow-up was 121 months. Two m3-patients (3.2%) died due to disease recurrence, including one patient in whom an ITC was detected. Conclusions: Lymphatic migration of tumor cells was found in node-negative m3- and sm1-adenocarcinomas of the esophagus (8.0% and 20.0%, respectively). However, the clinical relevance of these occult tumor cells should become apparent from large series of endoscopically treated patients. J. Surg. Oncol. 2010;102:863-867. (C) 2010 Wiley-Liss, Inc
AB - Background: Both endoscopic and surgical treatments are recommended for m3- or sm1-adenocarcinomas of the esophagus, depending on patients' lymph nodal status. Lymphatic dissemination is related to tumor infiltration depth, but varying incidences have been reported in m3- and sm1-adenocarcinomas. The study aim was to investigate whether the presence of occult tumor cells in lymph nodes could explain this variation. Methods: Sixty-three node-negative (NO) patients with early esophageal adenocarcinoma (m2/m3/sm1-tumors) were included. Multilevel-sectioning of lymph nodes was performed; sections were stained by means of immunohistochemistry with cytokeratin marker CAM5.2. Two pathologists searched for micrometastases (0.2-2.0 mm) and isolated tumor cells (ITCs, <0.2 mm). Results: Positive CAM5.2 staining in lymph nodes was not seen in any of the 18 m2-patients. In 2/25m3-tumors (8.0%) an ITC was found, but no micrometastases. Tumor cells were identified in 4/20 sm1-tumors (20.0%): three micrometastases and one ITC. Median follow-up was 121 months. Two m3-patients (3.2%) died due to disease recurrence, including one patient in whom an ITC was detected. Conclusions: Lymphatic migration of tumor cells was found in node-negative m3- and sm1-adenocarcinomas of the esophagus (8.0% and 20.0%, respectively). However, the clinical relevance of these occult tumor cells should become apparent from large series of endoscopically treated patients. J. Surg. Oncol. 2010;102:863-867. (C) 2010 Wiley-Liss, Inc
U2 - https://doi.org/10.1002/jso.21719
DO - https://doi.org/10.1002/jso.21719
M3 - Article
C2 - 20872812
SN - 0022-4790
VL - 102
SP - 863
EP - 867
JO - Journal of surgical oncology
JF - Journal of surgical oncology
IS - 7
ER -